Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

publishing date : 2021 - 03 - 15    tags : Pharm-country    save search

Update on Finalization of MCIT Rule to Provide National Medicare Coverage for FDA Breakthrough Devices and Diagnostics
Published: 2021-03-15 (Crawled : 19:00) - biospace.com/
RNLX | $0.6521 -6.78% 250K twitter stocktwits trandingview |
Technology Services
| | O: -7.13% H: 11.53% C: 8.09%

fda device diagnostics diagnostic
STRATA Skin Sciences Announces Independent Study Published in the Journal of The European Academy of Dermatology and Venereology
Published: 2021-03-15 (Crawled : 19:00) - biospace.com/
SSKN | $0.5599 3.69% 3.5K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 7.37% C: 5.26%

skin
PTC Presents Results from a Real-World Study of Steroid Switching in the Treatment of Patients with Dystrophinopathies
Published: 2021-03-15 (Crawled : 15:00) - biospace.com/
PTCT | News S | $25.42 0.04% 230K twitter stocktwits trandingview |
Health Technology
| | O: -0.68% H: 1.43% C: 0.03%

treatment results
Sanofi and Regeneron Halt Cervical Cancer Trial Early Due to Dazzling Results, Plan to Submit to ...
Published: 2021-03-15 (Crawled : 15:00) - biospace.com/
SNY | News | $46.765 -1.94% 950K twitter stocktwits trandingview |
Health Technology
| | O: 0.85% H: 0.89% C: 0.6%

results cancer trial
DAXOR CORPORATION ANNOUNCES NOVEL FLUORESCENT TRACER AND PHASE-TWO US AIR FORCE CONTRACT AWARD OF $750,000 FOR POINT-OF-CARE OPTICAL BLOOD VOLUME ANALYZER
Published: 2021-03-15 (Crawled : 14:00) - biospace.com/
DXR | $9.8 860 twitter stocktwits trandingview |
Health Technology
| | O: 2.06% H: 2.42% C: 2.42%

blood optical contract
Data from STEP clinical trial program evaluating effect of semaglutide 2.4 mg in people with obesity to be presented at 2021 ENDO annual meeting
Published: 2021-03-15 (Crawled : 14:00) - biospace.com/
NVO | News | $126.09 -1.98% 2.2M twitter stocktwits trandingview |
Health Technology
| | O: 0.52% H: 0.99% C: 0.99%

obesity ev trial
Timber Pharmaceuticals Announces 50% Enrollment in Phase 2b CONTROL Study in Congenital Ichthyosis
Published: 2021-03-15 (Crawled : 14:00) - biospace.com/
TMBR | $0.3426 -2.69% 3K twitter stocktwits trandingview |
Health Technology
| | O: 4.84% H: 2.69% C: -5.38%

phase 2 phase 2b enroll
CorMedix Approved to Sell $1.3 Million of NOL Tax Benefits Through The New Jersey Economic Development Authority Program
Published: 2021-03-15 (Crawled : 14:00) - biospace.com/
CRMD | $5.405 -0.83% 190K twitter stocktwits trandingview |
Health Technology
| | O: 0.97% H: 0.0% C: -1.38%

ev authorized
Chief Medical Officer of electroCore, Inc. Peter Staats, M.D. Describes Potential At-Home Solutions to Reduce Common COVID-19 Symptoms
Published: 2021-03-15 (Crawled : 14:00) - biospace.com/
ECOR | $5.98 5.65% 1.4K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 3.74% C: 2.8%

covid potential
Zora Biosciences Licenses Ceramide Technology to Quest Diagnostics for Cardiovascular Mortality Prediction Test
Published: 2021-03-15 (Crawled : 14:00) - biospace.com/
DGX | News | $138.13 1.05% 690K twitter stocktwits trandingview |
Health Services
| | O: -0.21% H: 1.65% C: 1.44%

cardiovascular test license cardio diagnostics bioscience diagnostic
Cyclacel to Present at the Oppenheimer 31st Annual Healthcare Conference
Published: 2021-03-15 (Crawled : 12:00) - biospace.com/
CYCC | $2.18 21.79% 95K twitter stocktwits trandingview |
Health Technology
| | O: -1.59% H: 20.46% C: 16.96%

conference presentation
Windtree to Present at the Oppenheimer 31st Annual Healthcare Conference
Published: 2021-03-15 (Crawled : 12:00) - biospace.com/
WINT | $5.085 -10.53% 46K twitter stocktwits trandingview |
Health Technology
| | O: 1.67% H: 2.35% C: -6.57%

conference presentation
Scopus BioPharma Finalizes Arrangements for Submission of IND Package
Published: 2021-03-15 (Crawled : 12:00) - biospace.com/
SCPS | $0.1682 twitter stocktwits trandingview |
| | O: 1.76% H: 2.24% C: 1.73%

biopharma submission
BioXcel Therapeutics Receives FDA Breakthrough Therapy Designation for BXCL501 for the Acute Treatment of Agitation Associated with Dementia
Published: 2021-03-15 (Crawled : 12:00) - biospace.com/
BTAI | News | $2.74 -7.74% 790K twitter stocktwits trandingview |
Health Technology
| | O: 5.93% H: 0.01% C: -2.14%

treatment fda dementia therapy breakthrough therapy designation
Gainers vs Losers
59% 41%

Top 10 Gainers
CZOO | $10.52 110.82% 10M twitter stocktwits trandingview |

CSSE 4 | $0.3181 108.86% 170M twitter stocktwits trandingview |
Consumer Services

BOF | $1.87 59.83% 100M twitter stocktwits trandingview |

AMST | $3.1 55.0% 66M twitter stocktwits trandingview |
Technology Services

LICN | $0.85 51.79% 13M twitter stocktwits trandingview |

WIMI | $1.03 41.99% 15M twitter stocktwits trandingview |
Technology Services

SKIL 4 | $8.045 40.89% 230K twitter stocktwits trandingview |
Information

MULN | News | $3.805 39.38% 11M twitter stocktwits trandingview |
Information

RILY | $30.01 38.17% 11M twitter stocktwits trandingview |
Finance

MTC | $3.04 35.71% 6.7M twitter stocktwits trandingview |
Technology Services


Your saved searches
Save your searches and get alerts when important news are released.